指南与共识传染病防控与疫情报告卫生政策与健康促进

地方公共卫生机构使用整合基因组监测:基于德国2023年采用现状、应用与成功因素的混合方法研究的建议

Use of integrated genomic surveillance by local public health authorities: Recommendations based on a mixed-methods study of current adoption, applications and success factors, Germany, 2023.
指南 / 共识 · Euro Surveill · 2025-01-01

该研究采用混合方法,在德国三个州调查60个地方公共卫生机构(LPHAs)并开展五个定性案例研究,描述其使用整合基因组监测(IGS)的方式及实施所需因素。约半数机构报告已采用IGS,应用包括暴发分析、感染控制措施 targeting 与评估及传播链特征描述;基于成功案例提出在LPHAs层面实施IGS的建议。

要点

  • 约半数受访LPHAs报告已采用整合基因组监测(IGS)。
  • IGS应用包括暴发分析、感染控制措施 targeting 与评估及传播链特征描述。
  • 实施所需因素包括快速样本到结果周转时间、组织数据解读能力及明确监测采样策略。

核心结论

  • 该分析为在德国及其他公共卫生体系结构相似的国家增加LPHAs对IGS的实施铺平道路。

研究设计与样本

  • 混合方法设计,结合对德国三个州60个LPHAs的定量调查与基于四个德国地点LPHAs及一个州级公共卫生机构的五个定性案例研究。

主要发现

  • 约半数LPHAs报告采用IGS;应用包括暴发分析(n=25)、感染控制措施 targeting(n=25)与评估(n=18)及病原体传播链特征描述(n=25)。

关键数值与推荐

  • 实施IGS所需或重要的因素包括快速样本到结果周转时间、组织数据解读能力及明确定义的监测采样策略。

临床怎么用

  • 基于成功采用IGS的案例研究,作者提出在LPHAs层面实施IGS的建议,包括在LPHAs内建立专门IGS分析团队、使用用户友好数字方案(如基于浏览器的仪表板)进行数据交换与分析,以及与当地学术机构合作实施IGS。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BackgroundIntegrated genomic surveillance (IGS), i.e. the integrated analysis of pathogen whole genome sequencing and classical epidemiological data, can contribute substantially to the disease surveillance and infection prevention activities of local public health authorities (LPHAs).AimOur aim was to characterise how LPHAs use IGS, and factors required or important for their implementation, in the context of the German public health system.MethodsWe employed a mixed-methods design combining a quantitative survey of 60 LPHAs in three German states with five qualitative case studies based on LPHAs in four German localities and one state-level public health authority.ResultsApproximately half of LPHAs reported adoption of IGS; applications included outbreak analysis (n = 25), targeting and evaluation of infection control measures (n = 25 and n = 18, respectively) and characterisation of pathogen transmission chains (n = 25). Factors identified as required or important for the implementation of IGS in LPHAs included fast sample-to-result turnaround times, organisational data interpretation capabilities and clearly defined surveillance sampling strategies. Based on the case studies in which the adoption of IGS was successful, we formulate recommendations for implementing IGS at the level of LPHAs, including establishment of dedicated IGS analysis teams within LPHAs, use of user-friendly digital solutions (e.g. browser-based dashboards) for data exchange and analysis, and implementation of IGS in collaboration with local academic institutions.ConclusionOur analysis paves the way for increasing the implementation of IGS by LPHAs in Germany and other countries with similarly structured public health systems.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. Bludau A, Jack A, Fischer N, et al. Use of integrated genomic surveillance by local public health authorities: Recommendations based on a mixed-methods study of current adoption, applications and success factors, Germany, 2023. Euro Surveill. 2025. PMID: 40183123. doi:10.2807/1560-7917.ES.2025.30.13.2400508

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。